The most widely applied immunotherapies against advanced gastric cancer including immune checkpoint inhibitors (ICIs), adoptive cell therapy, cancer vaccine, vascular endothelial growth factor A (VEGFA) antibody and chimeric antigen receptor (CAR) T therapy, etc (8–10). The gene discussed is VEGFA; the disease is gastric cancer.